A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
What the Patent Covers U.S. Patent No. 9,593,333 claims methods, compounds and compositions for reducing the expression of apolipoprotein C-III (ApoC-III) mRNA and protein using antisense technology. In plain language: These claims are broad enough…
-
Biodegradable lipids for the delivery of active agents
What This Patent Covers This patent protects a class of biodegradable lipid molecules and related lipid particle compositions designed to deliver active agents such as nucleic acids (e.g., siRNA or mRNA) into cells. Specifically: Why…
-
Methods of Treating Crohn’s Disease and Ulcerative Colitis
While AbbVie’s full immunology patent estate includes many related filings, one of the core U.S. composition-of-matter patents for upadacitinib underpins Rinvoq’s exclusivity. According to regulatory listings, patents covering upadacitinib (Rinvoq) include U.S. Patent No. 11,564,922…
BioTech IP Review 